GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Jun 6, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
TL;DR
GSK is buying back its own stock via Merrill Lynch.
AI Summary
GSK plc announced on June 6, 2025, that it has purchased a number of its own ordinary shares through its corporate stockbroker, Merrill Lynch International. The filing does not specify the exact number of shares or the total dollar amount involved in these transactions.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine filing reporting on share repurchases, which is common corporate activity.
Key Players & Entities
- GSK plc (company) — The company making the share purchases.
- Merrill Lynch International (company) — The corporate stockbroker acting on behalf of GSK plc.
- June 6, 2025 (date) — The date of the announcement and the period covered by the report.
FAQ
What is the total number of GSK plc ordinary shares purchased?
The filing states that GSK plc has purchased 'the following number of the Company's ordinary shares' but does not specify the exact quantity in the provided text.
What is the total dollar amount spent on the share repurchases?
The filing does not disclose the total dollar amount spent on the share repurchases.
Who is acting as GSK plc's corporate stockbroker for these transactions?
Merrill Lynch International is acting as GSK plc's corporate stockbroker.
What is the nominal value of GSK plc's ordinary shares mentioned in the filing?
The ordinary shares are described as having a nominal value of 31¼ pence each.
What type of SEC filing is this report?
This is a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 6, 2025 regarding GSK plc (GLAXF).